WellTheory, a virtual care platform for autoimmune patients, is launching a program for postpartum women.
The Postpartum Program was driven by customer demand, executives said, and is designed to support women navigating hormonal shifts that can trigger or worsen autoimmune symptoms after birth. The program combines dietitian and coaching support with hormone testing to identify root causes of conditions.
Autoimmune disease affects more than 50 million Americans, with 80% of individuals affected being women. This is reflected in WellTheory numbers: Nearly three-quarters of its patients are women. Hormonal changes through major life phases like puberty, pregnancy and menopause are a major driver of new diagnoses or flare-ups. The average WellTheory member is a woman in her 40s that has more than one child.
“These moments are key moments when new symptoms are going to come up, when new triggers are going to show their faces,” Wallace Torres, co-founder of WellTheory, told Fierce Healthcare in an advanced interview. “Can we get on top of these early before the disease progresses?” Torres’ own wife struggled with an autoimmune journey after the birth of their child, becoming allergic to perfume and garlic, for example.
Busy doctors in the traditional system are not prepared to support a patient for 30 minutes, twice a month, to work through their goals and inspire behaviorial change. “Autoimmune is complex, and your typical doctor does not have the time to sit down with you and get you to make the kinds of changes that are going to have the long-term impact and support,” Torres said. “Changing your lifestyle and how you eat, that seems fairly simple, but we know that’s really really hard.”
WellTheory’s offering will generally be a 12-month program for employers, with the first part of the program focused on implementation and the second half on maintenance.
“We know that early intervention for these conditions can help you avoid a full-blown diagnosis down the line,” Torres said. “There’s a real ability here to control costs.”
The care team at WellTheory includes registered dietitians and board-certified health coaches. They take a combined approach of diet and lifestyle changes, considering triggers like unstable blood sugar, sleep issues or stress. Lab and hormone testing can further indicate adrenal dysfunction, postpartum depression and more. The company does not offer medication management, partnering with patients’ existing care providers, of which its members typically have three.
The Postpartum Program builds on existing WellTheory products, including a woman’s health program focused on hormonal conditions like polycystic ovary syndrome and menopause. In 2025, WellTheory published data on its enterprise offering based on clinically validated health outcomes questionnaires. It claims 81% of members report improved digestive symptoms; 55% report improvements in fatigue; about 45% report improvements in overall pain and sleep; and a third of members report improvements in mental clarity.
The company also aims to address the mental health needs of patients and said 61% of members reported improvements in depression while 60% improved in anxiety. Employees with autoimmune disease reported a 69% reduction in how often their symptoms got in the way of their work.
According to analysis from a third-party actuarial insights company, WellTheory’s core offering led to 71% reduced costs of imaging services; a 64% drop in ED visit costs; a 38% drop in overnight hospital stay costs; and a 15% reduction in biologics utilization costs. For employers who adopt its solution, WellTheory’s model provides an average of $9,389 in savings per patient on biologics and $5,181 in savings per patient, across all autoimmune patients, on a risk-adjusted basis.
In addition to employers like the Maven Clinic, WellTheory more recently began working with commercial plans, now reaching half a million covered lives. While payers may have general pregnancy support programs, the goal of the Postpartum Program is to recognize that the postpartum period is a major inflection point in an autoimmune journey.
“From the employers, there’s a lot of excitement around this particularly as a number of our partners have high female workforces, many of them in their 30s and 40s. They’re trying to retain these members,” Torres said.
link
